Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:06.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.3 to v3.5.0. This appears to be a minor version update with no substantive changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-25T20:16:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    - Added a Resources entry linking to the Genetic and Rare Diseases Information Center for Malignant Pleural Mesothelioma.
    Difference
    0.2%
    Check dated 2026-03-18T13:47:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T11:16:28.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Site update adds Revision: v3.4.2 and removes the prior funding notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T01:40:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the page revision tag updated to v3.4.1, while the previous revision tag v3.4.0 was removed.
    Difference
    0.5%
    Check dated 2026-02-04T00:00:38.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.